Oxandrolone 10 - Genetic Pharmaceuticals

Oxandrolone was first commercialized as Anavar by G.D. Searle & Co. in 1962, offering a unique balance between anabolic potency and reduced androgenic side effects. It quickly became useful in pediatric growth failure, involuntary weight loss, and long-term recovery from illness. The drug's safety record was a key reason for its global distribution. However, negative public sentiment toward anabolic steroids caused its withdrawal in 1989. Years later, Oxandrin revived the molecule under narrow clinical indications, especially for muscle-wasting conditions tied to serious disease.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxandrolone 10 by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.